Drawing for CADENCE

USPTO serial 90978524

CADENCE

Reviewed by CopyMark Law Group

Status 622
Filing date
—
Status date
Registration date
—
Examiner
—
Law office
UNKNOWN

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CADENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David P. Sharrow

David P. Sharrow GUNDERSON DETTMER STOUGH VILLENEUVE FRANKLIN & HAC1250 BROADWAY23RD FLOORNEW YORK, NY 10001

Goods and services

ClassDescriptionStatusFirst use
009Body weight measuring devices, namely, scalesACTIVEAug 12, 2021
010Blood glucose monitorsACTIVE—
042Providing online non-downloadable computer software applications and computer software platforms for remote monitoring and management of data; Providing online non-downloadable software for purposes of monitoring and predicting medical conditions; Providing online non-downloadable software for purposes of monitoring and predicting health and wellness, all used in connection with remote patient monitoring and remote provision of medical care; Software as a service (SAAS) services featuring software for monitoring and predicting medical conditions; Software as a service (SAAS) services featuring software for monitoring and predicting health and wellness, all used in connection with remote patient monitoring and remote provision of medical care; Software as a service (SAAS) services featuring software for enabling secure video and text communication between a patient and medical professionals, caregivers and family members; software as a service (SAAS) services featuring software for use in remote patient care management, and for facilitating communication between patients and medical professionals, caregivers and family members; software as a service (SAAS) services featuring software for remote patient care observations; software as a service (SAAS) services featuring software for integrated health care plan management and for comprehensive reporting on patient's condition; Software as a service (SAAS) services featuring computer software for educating and guiding patients, caregivers, family members, and healthcare providers through custom clinical protocols; Providing temporary use of online non-downloadable software for chronic disease management, diabetes management solution, health management, facilitating communication among doctors, medical professionals, medical care providers, and patientsACTIVEAug 12, 2021
044Providing an Internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the website that can be accessed in real-time by medical professionals for the purposes of monitoring, treating, predicting, and providing decision support for medical conditions; Providing healthcare information via wearable medical sensors and non-wearable medical devices; Remote monitoring of data indicative of the health or condition of an individual for medical treatment, prediction, and decision support purposes; Medical assistance services; Medical assistance services provided via telecommunication and global computer networks; Health care services, namely, remote patient medical vital sign monitoring; Medical diagnostic monitoring, reporting, and predicting, and treatment decision support services; Medical information services and consultations provided via the telephone and the Internet; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Medical assistance services provided via telecommunication, video conferencing and global computer networks for individuals with health problems through the use of personal medical devices with automated alert and interactive medical monitoring capacity that reminds individuals of pertinent medical information, namely, vital measurements, medicinal information, and health counseling; Health care services, namely, remote monitoring and managing of medical conditions via a cellular-enabled cloud based service; Electronic monitoring and reporting of remote medical vital signs using computers or sensorsACTIVEAug 12, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 25, 2022ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Sep 25, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 25, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 5, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 19, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 4, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 4, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Jan 4, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 4, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 4, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 1, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 30, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 30, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 12, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2021DOCKASSIGNED TO EXAMINER—
Mar 23, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 1, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance